Stanford PD Community Blog

Stanford Parkinson's Community
  • Home
You are here: Home / Webinars - Announcements & Notes / “Until there’s a cure: living your best life with Parkinson’s disease” – Webinar notes

“Until there’s a cure: living your best life with Parkinson’s disease” – Webinar notes

January 25, 2022 By Parkinson's Community Help

The American Parkinson Disease Association (APDA) held a webinar in December focused on the role and effectiveness of modern medications in Parkinson’s disease (PD) progression, and described two drug therapy approaches. The speaker, movement disorder specialist Dr. Drew Falconer, detailed how contemporary (modern) drug therapy is far superior and preferred in comparison to the classic paradigm for drug therapy.  Dr. Falconer noted that today (modern drug therapy) we have 23 medications to treat PD and 12 of them did not exist five years ago.  Additionally, Dr. Falconer explained the importance of diagnosing PD correctly as many times PD-like symptoms happen to be parkinsonism but not Parkinson’s disease. 

Here is an interesting excerpt from Dr. Falconer: 

“When PD becomes overwhelming, take a deep breath and think about it just as a chemical problem.  And if it’s just a chemical problem, we need to treat ourselves in a better way so our lives are smoother on a day to day basis.” 

This APDA webinar was recorded, and is accessible on YouTube.

For more resources on medication, please see this Stanford Parkinson’s Community Outreach webpage:

Medications for Parkinson’s Disease

See my notes below for the session. 

Regards, 

Sheela Sakariya


“Until there’s a cure: living your best life with Parkinson’s disease” – Webinar notes

Webinar Host:  American Parkinson Disease Association (APDA)

Webinar Date:  December 17, 2021

Speaker:  Drew Falconer, MD, movement disorders specialist, Virginia Commonwealth University

Summary by:  Sheela Sakariya, Stanford Parkinson’s Community Outreach

Parkinson’s disease in 2021 

There are many new frontiers in research and care for Parkinson’s disease (PD) that did not exist 15-20 years ago.  We are making progress in finding more medications to help symptoms for PD.  Today, we have 23 medications to treat PD and 12 of them did not exist five years ago. 

Have the courage to talk to someone about how your day is going and how your medicine is letting you down or helping you.  Essentially we want you to talk about why you can’t do what you want to do and keep advocating for yourself and the disease. 

Parkinson’s disease statistics 

PD is the second fastest growing neurological disease today.  We are currently treating 1 million people in the US for PD.  By 2030, it is estimated that we will be treating 1.2-1.5 million people with PD in the US.  Among folks over the age of 60, 1 in 100 already have PD.  We are diagnosing between 60,000-80,000 people every year with PD.  

It’s important to educate yourself if you have been diagnosed and advocate for yourself – find others under similar circumstances and comfort yourself in knowing that you are not alone.  There are many others in similar situations and looking for the same group camaraderie. 

What is PD? 

PD is not a structural problem – this is not a disease that comes from a tumor, mass or stroke.  PD does not represent permanence of injury.  For example, after a stroke, part of the brain is permanently damaged.  The structure of the brain is not a problem in PD, but PD means there is a chemical deficiency in the brain.  That chemical that the PD individual is lacking is dopamine!  WIth dopamine deficiency, an individual is not getting enough dopamine which results in movement disorders.  When there is too much dopamine, you see dyskinesia (excessive movements).  Dyskinesia is a side effect of the medicine, not a symptom of PD. 

When PD becomes overwhelming, take a deep breath and think about it just as a chemical problem.  And if it’s just a chemical problem, we need to treat ourselves in a better way so our lives are smoother on a day to day basis.  

PD is not an inherited disease and classically not something that runs in families.   There can be several factors that cause PD including: 

  • Pesticides including Agent Orange
  • Well water
  • Heavy metal exposure
  • Chemical exposure
  • Head injury

Diagnosis of PD

It’s extremely important to diagnose PD correctly as there are still people who get misdiagnosed.  Proper diagnosis is key to proper treatment!  The most common way to diagnose PD is to note the individuals’ symptoms and history that they present to us. After that, we do a quick exam to check the symptoms.  In most cases, we will give dopamine medications that will show you the benefits of the medications.  Using the medications will make the PD symptoms better. 

PD starts many years before diagnosis (perhaps 10-20 years before diagnosis).  It takes the brain to be dopamine deficient by about 60% for the motor symptoms to start showing such as tremor, shaking, trouble walking.  When the brain is about 30% down, the triad of symptoms include constipation, REM behavior-sleep disorder, and reduced sense of smell.  So, the progression for PD is slow – 20 years to see initial symptoms. 

OFF Time

Know what you feel!  Part of your day is trying to maintain the amount of dopamine in your brain and part of your day will be when the medicine lets you down and the symptoms are coming out.  That latter part of the day in PD is called the “OFF” time.  Talk to your doctor about the OFF time and if we can fix the OFF time, then we can fix PD.  

OFF time can happen anytime and it’s best to keep track of it.  Types of OFF time include:

  • First AM off
  • End of dose
  • Suboptimal on
  • Sudden off
  • Dose failure
  • Exercise-induced
  • Food-induced

70% reported 2+ OFF episodes a day

65% reported 2 or more hours a day

50% moderate/severe, affected daily activities 

Mimickers of PD

With PD, the healthcare professional will give you medication and the symptoms get better.  With Parkinson-isms, a person may suffer from the same symptoms as PD but there is limited medication response.  Some of the Parkinson-isms include

  • Vascular Parkinson’s
  • Medication induced Parkinson’s 
  • Parkinson’s plus syndromes
    • Multisystem atrophy
    • Progressive supranuclear palsy
    • Corticobasal degeneration

DIfferent approaches to therapy: Contemporary/modern approach is preferred

Classic treatment paradigm

  • Pulsatile and frequent
  • Higher and higher doses
  • Leads to fluctuations
  • Early side effects
  • Treatment horizon

Contemporary treatment paradigm

  • 23 different medications that stabilize dopamine
  • Predictable and long acting
  • Low doses, multiple targets
  • “Rational polypharmacy” – use different medications to target different symptoms
  • Employ technology earlier
  • Smoother
  • Reduced side effects

Medication categories for PD

New dopamine (levodopa) approach:

Rytary (carbidopa/levodopa)

  • Updated formulation to deliver carbidopa-levodopa
  • Can last from 5-8 hours compared to 2-3 hours for sinemet
    • 1-2 hours less off time
    • 2 hours more on time without dyskinesia

Non-dopamine approach:

Indirect pathway – activation reduces motor activity

  • Direct pathway increases activity (dopamine, etc.)
  • Indirect pathway inhibits motor activity (adenosine, GABA)

Adenosine A2a receptor antagonist

  • Double neg locks the block
  • Improves off times, releasing the “brake” on the system

Maximize your levodopa:

Ongentys (opicapone)

  • 1x daily inhibitor of COMT enzyme
  • Boosts levodopa for 24 hours
  • Blocks breakdown of levodopa in the periphery, making more available to the brain
  • In use in europe since 2016
  • Once daily at bedtime away from food

Dyskinesia and OFF episodes

Gocovri (amantadine ER)

  • 1st daily amantadine ER at bedtime
  • First “FDA approved” therapy for dyskinesia AND off periods
  • Used to reduce dyskinesia (37% reduction or elimination)
  • Reduced OFF time by 45% during the day

Rescue option 1

Apokyn (apomorphine injection)

  • Rapid onset dopamine agonist via injection
  • For different types of OFF episodes:
    • Rapid off, wearing off
    • Dose failure/unexpected off
    • Delayed on
    • First AM symptoms or exercise intolerance
  • Achieve ON within 10-20 minutes

Rescue option 2

Inbrija (levodopa inhalation powder)

  • Rapid onset levodopa through inhaler
  • For different types of OFF episodes:
    • Rapid off, wearing off
    • Dose failure/unexpected off
    • Delayed on
    • First AM symptoms or exercise intolerance
  • Achieve ON within 10 minutes, can take upto 5x daily

Rescue option 3

Kynmobi (apomorphine sublingual film)

  • Sublingual dissolving film for “off” episodes
  • Improvement begins after 15 minutes 
  • For different types of OFF episodes:
    • Rapid off, wearing off
    • Dose failure/unexpected off
    • Delayed on
    • First AM symptoms or exercise intolerance
  • Can take upto 5x daily

Orthostatic hypotension (OH)

Northera (droxidopa)

  • OH is common symptom of PD
  • Can be worsened by dopamine supplementation
  • Prodrug (precursor of a drug) for Norepinephrine, crosses BBB

Future medications and technologies lead us to hope for better treatment of PD

  • Longer acting levodopa formulation (10 hours or greater)
  • New inhibitors
  • Pump-based and subcutaneous formulations
  • Improved technology
  • Targeted protein therapy
  • Cure

Filed Under: Webinars - Announcements & Notes

  • Home

Categories

  • Monthly List – PD Webinars
  • Webinars – Announcements & Notes
  • Monthly List – Caregiving Webinars
  • Monthly List – Support Groups
  • Support Groups – Meetings & Notes
  • News
  • Research
  • Events
  • Exercise
  • Comment

Top Pages of the Stanford Parkinson’s Community Outreach Website

  • List of Live, Virtual PD Exercise Classes
  • List of PD Exercise Videos
  • Symptoms of PD
  • For Those Newly Diagnosed
  • Support Resources for PD

Featured Posts

Your top three Parkinson’s questions answered by the APDA

The American Parkinson Disease Association (APDA) recently shared the top three questions they are … [Read More...]

National Day of Action – Thursday, September 22, 2022

From the American Parkinson Disease Association, Northwest Chapter (APDA NW), Tuesday, September … [Read More...]

Archive

  • January 2023 (3)
  • December 2022 (7)
  • November 2022 (4)
  • October 2022 (9)
  • September 2022 (2)
  • August 2022 (3)
  • July 2022 (5)
  • June 2022 (6)
  • May 2022 (9)
  • April 2022 (5)
  • March 2022 (8)
  • February 2022 (5)
  • January 2022 (13)
  • December 2021 (7)
  • November 2021 (19)
  • October 2021 (14)
  • September 2021 (12)
  • August 2021 (9)
  • July 2021 (7)
  • June 2021 (10)
  • May 2021 (10)
  • April 2021 (16)
  • March 2021 (8)
  • February 2021 (27)
  • January 2021 (18)
  • December 2020 (18)
  • November 2020 (19)
  • October 2020 (13)
  • September 2020 (7)
  • August 2020 (12)
  • July 2020 (15)
  • June 2020 (13)
  • May 2020 (17)
  • April 2020 (14)
  • March 2020 (14)
  • February 2020 (5)
  • January 2020 (12)
  • December 2019 (10)
  • November 2019 (6)
  • October 2019 (6)
  • September 2019 (7)
  • August 2019 (5)
  • July 2019 (10)
  • June 2019 (3)
  • May 2019 (8)
  • April 2019 (10)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (12)
  • December 2018 (2)
  • November 2018 (8)
  • October 2018 (10)
  • September 2018 (2)
  • August 2018 (7)
  • July 2018 (10)
  • June 2018 (9)
  • May 2018 (3)
  • April 2018 (10)
  • March 2018 (4)
  • February 2018 (8)
  • January 2018 (11)
  • December 2017 (11)
  • November 2017 (5)
  • October 2017 (11)
  • September 2017 (10)
  • August 2017 (7)
  • July 2017 (13)
  • June 2017 (10)
  • May 2017 (14)
  • April 2017 (12)
  • March 2017 (17)
  • February 2017 (11)
  • January 2017 (13)
  • December 2016 (4)
  • November 2016 (6)
  • October 2016 (1)
  • September 2016 (11)
  • August 2016 (5)
  • July 2016 (8)
  • June 2016 (4)
  • May 2016 (2)
  • April 2016 (2)
  • March 2016 (1)
  • February 2016 (1)
  • January 2016 (4)
  • December 2015 (1)
  • November 2015 (2)
  • October 2015 (3)
  • September 2015 (1)
  • August 2015 (3)
  • July 2015 (1)
  • June 2015 (1)
  • May 2015 (1)
  • April 2015 (2)
  • March 2015 (4)
  • February 2015 (2)
  • January 2015 (1)
  • December 2014 (1)
  • November 2014 (2)
  • October 2014 (1)
  • September 2014 (2)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (5)
  • May 2014 (1)
  • April 2014 (2)
  • March 2014 (3)
  • February 2014 (1)
  • January 2014 (1)
  • December 2013 (1)
  • November 2013 (1)
  • October 2013 (1)
  • September 2013 (1)
  • August 2013 (1)